Biostimulators have moved from a niche add-on to a core part of most successful practices’ treatment menus, but the category has grown crowded enough that practitioners are increasingly asking how Juvelook, Lenisna, Profhilo and Sunekos actually compare, and whether a practice genuinely needs all four.
Comparing Juvelook, Lenisna, Profhilo & Sunekos
Juvelook, built on PDRN and polynucleotide-hydrogel technology, is particularly strong for overall skin quality and fine lines, working by stimulating fibroblast activity directly. It’s frequently chosen for patients whose main complaint is a generally tired, dull complexion rather than pronounced laxity, and tends to suit slightly younger patients starting to notice early signs of collagen decline rather than those with more advanced skin changes.
Lenisna sits in a genuinely hybrid space, offering both structural support and biostimulatory benefit, useful for patients needing a degree of volume correction alongside skin quality improvement, making it a good option for practitioners wanting to reduce the number of separate product categories needed to address a patient with mixed concerns.
Profhilo, using its distinctive bio-remodeling mechanism, excels specifically at treating skin laxity in areas like the neck, lower face and hands with minimal injection points, and remains the most differentiated option of the four given how mechanistically distinct its BAP technique is from standard injection protocols.
Why Differentiation Beats Stocking Everything
Sunekos, formulated around amino acids and hyaluronic acid, is well regarded for stimulating both collagen and elastin production, often positioned for overall skin revitalization and under-eye rejuvenation, and tends to appeal to patients specifically seeking a more ‘natural’ sounding formulation given its amino acid basis, which can be a genuinely useful positioning point for more cautious patients newer to biostimulator treatment.
Rather than viewing these as competing products, most well-run practices benefit from stocking a small, deliberately differentiated selection, one product for skin quality and fine lines, one for laxity-specific bio-remodeling, and one hybrid option for patients needing structural support alongside regeneration, rather than trying to stock every biostimulator on the market and risk confusing both staff and patients with too many overlapping options.
This differentiation also makes consultations easier. Rather than trying to explain four broadly similar-sounding products, practitioners can confidently say ‘this one is for hydration and fine lines, this one is for laxity in the neck’, giving patients a clear, logical reason for the specific recommendation rather than a menu of interchangeable options that ultimately undermines confidence in the recommendation itself.
Pricing & Patient Communication
Price positioning across the four products is also worth planning deliberately rather than leaving to chance. Where products genuinely overlap in what they address, a clear price differential based on formulation cost and treatment protocol helps patients and staff alike understand that the choice between them is clinical, not just a menu of similarly priced alternatives to pick between at random.
As biostimulators become a bigger part of patient expectations, particularly among patients who’ve done their own research before booking, having a genuinely considered, differentiated range, rather than picking one product and using it for everything, is likely to matter more over the coming year, not less.
Review Our Biostimulator Range
To review our full biostimulator range and build a considered, differentiated menu for your practice, visit dradamsaesthetics.us.
